Skip to main content
. Author manuscript; available in PMC: 2024 Mar 20.
Published in final edited form as: Nat Med. 2022 Jun 23;28(8):1581–1589. doi: 10.1038/s41591-022-01856-6

Extended Data Fig. 5 |. Responders to Matched Targeted Therapy.

Extended Data Fig. 5 |

Details of 5 responders to matched targeted therapy. GAIN patient 317 with an ALK fusion in a medullary thyroid carcinoma also responded, with images available in the primary report (Hillier et al., 2019).